Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000032

Director sold 1,546 shares at $99.16 ($153,301)

  • Director acquired 1,546 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CARTER BRUCE L A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-11 Exercise or conversion : show line 1 in the form +1,546 $23.40 $36,176 1,546 D
2019-03-11 Sale : show line 2 in the form −1,546 $99.16 $153,301 0 D
Open-market sales · 1,546 sh · avg $99.16 · $153,301

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,546 $23.40 2023-11-22 1,546 0 D
Loading xslF345X03/edgar.xml…